{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T07:59:13Z","timestamp":1767945553420,"version":"3.49.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The use of preemptive thoracic endovascular aortic repair (TEVAR) has been expanding, especially in cases where aortic enlargement is an indication for surgical intervention. Current guidelines recommend treatment for chronic type B aortic dissection (TBAD) when aortic diameter increases by \u22655\u2005mm over a 6-month period. However, the optimal window for preemptive TEVAR is the subacute phase (up to 3 months), creating a dilemma where intervention may be delayed beyond this window. This study investigates the short- and long-term outcomes of aggressive treatment for rapidly enlarging aneurysms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and methods<\/jats:title>\n                    <jats:p>\n                      Between July 2004 and August 2024, 432 patients with acute Stanford type B aortic dissection were treated at two centers. Of these, 324 patients who completed acute best medical therapy (BMT) were included. Patients with rapid enlargement of aortic aneurysms who did not meet absolute surgical indications (aneurysm diameter &amp;lt;55\u2005mm and &amp;lt;5\u2005mm\/month) were compared to those who continued BMT. Propensity score matching was performed between the BMT group (Group B,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200983) and the aortic expansion group (Group E,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200983).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 324 eligible patients, 88 exhibited rapid aortic enlargement (\u22645\u2005mm in &amp;lt;6 months). Of these, 42 (48%) underwent surgical intervention: 12 (14%) received graft replacement, and 30 (34%) underwent TEVAR, with 28 (32%) receiving preemptive TEVAR. The BMT group continued without surgery, with 7 patients (3%) receiving graft replacement and 20 (8%) undergoing TEVAR. In Group E, aortic diameter significantly increased compared to Group B (0.4\u2009\u00b1\u20090.2 vs. 1.1\u2009\u00b1\u20090.2\u2005mm,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). The false lumen was thrombosed in all preemptive TEVAR patients (mean 3.2\u2009\u00b1\u20095.1 months). In addition, univariate Cox regression identified preemptive TEVAR as a significant protective factor against aorta-related events (HR: 0.03, 95% CI: 0.004\u20130.22,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), highlighting its potential role in reducing adverse aortic outcomes. The aorta-related death-free survival rates at 1, 5, and 10 years were 99\/99\/99% vs. 99\/93\/88% for Groups B and E, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.097). Seven deaths occurred in Group E, with six related to ruptured aortic aneurysms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Selective preemptive TEVAR for patients with rapid aortic enlargement in the subacute and chronic phases of TBAD showed favorable outcomes. Although no significant difference in aorta-related mortality was found, the higher incidence of rupture in untreated patients suggests that preemptive TEVAR may offer a benefit. Further research is needed to identify the patients most likely to benefit from early surgical intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1696381","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:36:02Z","timestamp":1767940562000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Validity of current surgical strategies for aneurysmal progression in post-subacute Stanford type B aortic dissection: a propensity score\u2013matched comparative analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Ken","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Akabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miku","family":"Konaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cholsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Shimanuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1253\/circj.CJ-22-0794","article-title":"JCS\/JSCVS\/JATS\/JSVS 2020 guideline on diagnosis and treatment of aortic aneurysm and aortic dissection","volume":"87","author":"Ogino","year":"2023","journal-title":"Circ J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s11748-023-01997-6","article-title":"Thoracic and cardiovascular surgeries in Japan during 2021: annual report by the Japanese association for thoracic surgery","volume":"72","author":"Yoshimura","year":"2024","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCINTERVENTIONS.113.000463","article-title":"Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial","volume":"6","author":"Nienaber","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.23736\/S0021-9509.16.09849-9","article-title":"Evidence for and risks of endovascular treatment of asymptomatic acute type B aortic dissection","volume":"58","author":"Clough","year":"2017","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jvs.2018.05.232","article-title":"Current evidence in predictors of aortic growth and events in acute type B aortic dissection","volume":"68","author":"Spinelli","year":"2018","journal-title":"J Vasc Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jvs.2017.11.089","article-title":"The incidence of delayed complications in acute type B aortic dissections is underestimated","volume":"68","author":"Reutersberg","year":"2018","journal-title":"J Vasc Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.avsg.2023.07.111","article-title":"Aortic remodeling after thoracic endovascular aortic repair for nonacute uncomplicated type B aortic dissection","volume":"99","author":"Nomura","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1442800","DOI":"10.3389\/fcvm.2024.1442800","article-title":"Safe and favorable prognosis of thoracic endovascular aortic repair for the low-risk patients with non-acute type B aortic dissection","volume":"11","author":"Nakamura","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ejvs.2021.02.026","article-title":"Timing and outcome of endovascular repair for uncomplicated type B aortic dissection","volume":"61","author":"Xie","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.21037\/jtd-24-864","article-title":"Narrow true lumen favors future complication even in small diameter of type B aortic dissection","volume":"16","author":"Nakamura","year":"2024","journal-title":"J Thorac Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3400\/avd.oa.18-00115","article-title":"Analysis of risk factors for aortic enlargement in patients with chronic type B aortic dissection","volume":"11","author":"Nakamura","year":"2018","journal-title":"Ann Vasc Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jama.2016.10026","article-title":"Acute aortic dissection and intramural hematoma: a systematic review","volume":"316","author":"Mussa","year":"2016","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.12945\/j.aorta.2014.14-040","article-title":"Type B aortic dissection: a review of prognostic factors and meta-analysis of treatment options","volume":"2","author":"Luebke","year":"2014","journal-title":"Aorta (Stamford)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jvs.2018.06.203","article-title":"Thirty-day outcomes from the society for vascular surgery vascular quality initiative thoracic endovascular aortic repair for type B dissection project","volume":"69","author":"Wang","year":"2019","journal-title":"J Vasc Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.21037\/jovs.2018.02.15","article-title":"Conservative management versus endovascular or open surgery in the spectrum of type B aortic dissection","volume":"4","author":"Yuan","year":"2018","journal-title":"J Vis Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e005709","DOI":"10.1161\/CIRCIMAGING.116.005709","article-title":"Computed tomography imaging features in acute uncomplicated stanford type-B aortic dissection predict late adverse events","volume":"10","author":"Sailer","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3400\/avd.ra.24-00012","article-title":"Interventions in acute or subacute phase for type B aortic dissection","volume":"17","author":"Kato","year":"2024","journal-title":"Ann Vasc Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jvs.2014.01.042","article-title":"Predictors of aortic growth in uncomplicated type B aortic dissection","volume":"59","author":"van Bogerijen","year":"2014","journal-title":"J Vasc Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"II107","DOI":"10.1161\/01.CIR.92.9.107","article-title":"Determining surgical indications for acute type B dissection based on enlargement of aortic diameter during the chronic phase","volume":"92","author":"Kato","year":"1995","journal-title":"Circulation"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1696381\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:36:03Z","timestamp":1767940563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1696381\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":20,"alternative-id":["10.3389\/fcvm.2025.1696381"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1696381","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1696381"}}